Albert Bourla (Photographer: Christopher Goodney/Bloomberg via Getty Images)

Pfiz­er will not make fu­ture in­vest­ments in Rus­sia but stops short of sev­er­ing all busi­ness ties, Bourla says

While many cor­po­ra­tions have end­ed their ties to Rus­sia as it con­tin­ues to wage war on Ukraine, Big Phar­ma has been large­ly ab­sent from its ranks. That changed — slight­ly — on Wednes­day with a new de­c­la­ra­tion from Pfiz­er CEO Al­bert Bourla.

Speak­ing on CBSFace the Na­tion pro­gram Wednes­day, Bourla said Pfiz­er will end plans for fu­ture in­vest­ment in Rus­sia while not cut­ting ties com­plete­ly. Bourla ar­gued that Pfiz­er still needs to pro­vide Russ­ian pa­tients with life­sav­ing drugs, re­gard­less of their gov­ern­ment’s ac­tions.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.